Andrew Tershakovec from Merck: Global Study Looks at Ability to Control Cholesterol Levels Locally

The approval of medications like statins and PCSK9 inhibitors to help lower cholesterol levels have proven helpful but a recent study looked at whether patients were getting not only the treatments they needed but whether they were getting the right dosage levels to help improve their health.

Speaking at the annual meeting of the American College of Cardiology in Chicago, Andrew Tershakovec, MD, from Merck, discussed the results of a study looking at how common correct treatments and dosages were in patient care. While the hope is that everyone is getting the treatment they need Tershakovec said there is an understanding that doctors and patients have individulaized comfort levels with medication which can play a role in how complaint they are with proper prescribing techniques and usage.